Skip to content

IVD Performance Evaluation

Aurevia helps manufacturers comply with the clinical evidence requirements of the IVD Regulation.

Performance evaluation

Performance evaluation is a requirement in the In vitro Diagnostic Medical Devices Regulation 2017/746 (IVDR).
It refers to an assessment and analysis of data to establish or verify the scientific validity, the analytical and, where applicable, the clinical performance of a device.

Before any in vitro diagnostic medical device can be legally placed on the EU market, a manufacturer must comply with the requirements of the IVD Regulation. Clinical evidence shall support the intended use of the device and be based on a continuous process of performance evaluation.

Performance evaluation shall demonstrate the scientific validity, analytical performance and clinical performance of the device and it shall follow a performance evaluation plan. The clinical evidence derived from the performance evaluation shall provide scientifically valid assurance that the relevant safety and performance requirements of the IVD Regulation are fulfilled.

AUREVIA

How can we help?

Aurevia helps manufacturers comply with the clinical evidence requirements of the IVD Regulation by:

  • making the performance evaluation plan
  • making plans and reports for analytical performance studies
  • demonstrating the scientific validity through a systematic literature review
  • making plans and reports for clinical performance studies
  • making the performance evaluation report
female-entrepreneur-talking-colleague

Explore our services

labquality_com_24

Electrical Safety IEC 60601

IEC 60601-1 is the basic international safety standard for medical electrical devices and systems.

labquality_com_27

Biological Safety ISO 10993

International standard of biological safety evaluation process and preparing biological evaluation documentation for medical device manufacturers.

labquality_com_19

IVD Performance Evaluation

In vitro diagnostic medical device (IVD) regulations are set out in the EU In Vitro Diagnostics Regulation.

labquality_com_29

Qualification and classification of medical devices

Our team’s versatile experience and the available tools help in bringing clarity to the challenging cases.

young-man-using-laptop-desk-office

Regulatory plans

Regulatory plans for medical device manufacturers.

labquality_com_31

IVDR compliance for in-house developed tests

Laboratories developing IVDs in-house must maintain Technical Documentation and Quality Management Systems to comply with the IVDR and the national law.

labquality_com_8

Medical software

Adhering to medical device software regulations throughout the entire lifecycle.

labquality_com_25

Risk Management ISO 14971

Setting up and implementing a risk management system and preparing risk management documentation.

Contact us for more information

Meeri Säily
Meeri Säily
Sales Director, Consulting and Clinical Trials

Leave a contact request

Latest news

aurevia

Introducing Aurevia

Aurevia merges Labquality, Artimed, Kasve & Prisma CRO, uniting EQAS, clinical research & QA services. Offices in...

New EQA schemes for 2025

Introducing our new EQA schemes for 2025!
World Patient Safety Day is celebrated on 17 September

Patient Safety: The Cornerstone of Healthcare

Learn how Labquality supports patient safety in healthcare through external quality assessments, clinical trials,...

EQA Program 2025

The 2025 EQA program has now been published!

Does your device require a clinical investigation?

Clinical investigations are mandatory for certain medical devices in the EU. But how to know if your product requires a...